UPSHER-SMITH LAUNCHES TWO STRENGTHS OF BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
MAPLE GROVE, Minn., Nov. 9, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), today announced the recent launch of Brimonidine Tartrate Ophthalmic Solution 0.1% and Brimonidine Tartrate Ophthalmic...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 99 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.